NCT00413361View on ClinicalTrials.gov

The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS

PHASE4CompletedINTERVENTIONAL

Enrollment

543

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

versus hydroxychloroquine

versus hydroxychloroquine

Trial Locations (2)

75013

Chu Pitie Salpetriere, Paris

Hopital la Pitié Salpétrière Assistance Publique, Paris

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER